This is a good approach to get around having to use BSL3 containment facilities. The purpose of those studies was to assess the binding of the SARS-CoV-2 S protein to the ACE2 receptor using a pseudotyped lentivirus (HIV) system. These sorts of studies are common and very useful because the scientists don't have to use the whole SARS-CoV-2, which needs to be used in a BSL3 containment facility. Only the gene for the S protein (3,819 nucleotides; 12% of the genome) was inserted into the lentivirus vector,
pNL4-3.Luc.R-E-. This vector is based on HIV but does not contain functional Nef and Vpr, and has the Env gene deleted. Because the Env protein is needed for pseudovirus entry into cells another entry protein, which in this case is the S protein, needs to be inserted into the vector. The virus particles produced by pNL4-3.Luc.R-E- are then able to enter cells but because of the defective Nef and Vpr they cannot complete a full replication cycle and are unable to be transmitted. pNL4-3.Luc.R-E- also encodes a luciferase gene from the firefly. This is used as a marker to quantify the number of cells that the pseudotyped virus entered. A luciferin substrate can be added to the cells and a luminescent signal is produced by the luciferase. This allows the scientists to determine whether the pseudotyped viruses can enter cells using the ACE2 receptor but more importantly characterize mutations in the S protein that are critical for SARS-like viruses from bats to enter cells without using the actual viruses from bats. This is a very safe approach for studying zoonotic viruses with the potential to cause severe disease.